Angelini Ventures

Today marks an important milestone as the Angelini Industries Group unveils its first #ESG Strategic Plan, and at Angelini Ventures, we're proud to contribute to this transformative sustainability journey. We firmly believe that meaningful innovation in healthcare must embody an inclusive vision where access and equity are foundational principles. This conviction drives our dual commitment: investing in healthcare innovations that enhance equitable access to care, while promoting diversity and inclusion within our teams and portfolio companies. Angelini Industries' ambitious ESG roadmap, spanning People, Patients/Customers/Communities, Ecosystems, and the Planet, closely aligns with our own sustainability priorities. We're deeply engaged in contributing to this Group-wide effort, leveraging our active investor role to promote responsible, sustainable business practices across our portfolio. Read the full news in the press release https://lnkd.in/d6w-PCDB

🚀 Attention future VCs and career changers! 🎧 Ever wondered what it takes to break into the world of venture capital? 🤔💼 Our very own Lola Buono spills the tea on her journey from biotech studies to her VC role in the latest episode of "I lavori di domani" Radio 24 podcast with Anna Marino! 🎉 Key takeaways for aspiring VCs: 🔬 Rock a tech/science degree 📚 Dive deep into a specific field 💪 Learn by doing - nothing beats hands-on experience! Pro tip: Check out VC fellowship programs (like ours at Angelini Ventures https://lnkd.in/dvxumPcV) to get your foot in the door while still studying! 🚪🏃♀️ Ready to shape the future of innovation? Don't miss this episode! 🎧✨ https://lnkd.in/dhuJ3Mx3 (Note: Podcast is in Italian 🇮🇹) #VentureCapital #CareerAdvice #podcast Thank you, Angelini Industries and SEC Newgate Italia, for facilitating the development of this insightful content!

We invite you to watch this insightful video interview from BiotechTV, featuring our Medical Director, Fabrizio Calisti, in conversation with BiotechTV founder Brad Loncar. In this compelling discussion, Fabrizio discusses our current and future strategies to continue shaping the future of care. As concrete examples of these strategies in action, he spotlights two of our portfolio companies that many BiotechTV followers already know and appreciate: Pretzel Therapeutics and Nouscom . We'd like to extend our sincere thanks to Brad for visiting us in Rome and to BiotechTV for their important work in disseminating knowledge in the biotech sector. We're also grateful to MEDiSTRAVA, an Inizio Company for facilitating the connection that made this interview possible. #Biotech #HealthcareInnovation #FutureOfCare

One month after our first Angelini Ventures Healthcare Summit, we're excited to share this aftermovie that captures the spirit of innovation and collaboration that defined the event! This video isn't just a celebration of a successful event that brought together 100 key players in healthcare, including investors, experts, portfolio companies, and colleagues from Angelini Industries and Angelini Pharma. It reflects our two-year journey at Angelini Ventures (October 19th marks our official second anniversary! 🎉) and our core belief: innovation thrives on relationships. We extend our heartfelt thanks to all participants, with special gratitude to the speakers who shared their valuable perspectives in this video: thank you Jill Schiaparelli, MBA (Avation Medical), Baruch Harris (Pretzel Therapeutics), Suman Rao, PhD (Lumira Ventures), Shriram Raghunathan, Ph.D (Noctrix Health, Inc.). Here's to many more years of collaborative progress in healthcare! Video credits 🎬: Terroir Films

Just in from Italian Tech Alliance: the latest Quarterly Venture Capital Observatory data paints an exciting picture for Italian (and European) innovation landscape. Prepared with Growth Capital Partners and supported by CDP Venture Capital SGR and Zest Group, the numbers speak volumes. Key highlights: 🔸Q3 2024: €524 million invested, up from €228 million in Q2 🔸First 9 months of 2024: €1.195 billion across 247 rounds - already surpassing all of 2023! 🔸Notable increases in both Series A (13) and Series B (6) rounds Our CEO, Paolo Di Giorgio, joined a panel discussion emphasizing how CVC independence can drive innovation and bridge established businesses with startups. Kudos to Italian Tech Alliance and all participants for these valuable insights. Read the full report here https://lnkd.in/d3ubp3bN What's your take on these trends? Let's keep the conversation going! 

New week, new events to attend! On October 17th and 18th, Berlin becomes the epicenter of health innovation at the bcc - Berlin Congress Center, and we're proud to announce that our very own Elia Stupka and Nils Bottler will be attending Frontiers Health 2023! 📅 Mark your calendars for October 17th: 📌 Elia will be participating in the panel "The Path to Scaling Mental and Brain Health Solutions" 📌Nils will be joining the "Start-up and Scale-up Discovery" session number 2 Established in 2015, Frontiers Health is a highly curated event that brings together ecosystem leaders - founders, C-Suite executives, senior government officials, and academic thought leaders - to discuss the next frontier of innovation in health and life sciences. Attending Frontiers Health? Reach out to schedule a meeting with Elia or Nils during the event. Interested in joining us at Frontiers Health? Register now and get 25% off with the code FHSPX25 here: https://lnkd.in/dmdSEa3Q Don't miss this opportunity to be part of shaping the future of healthcare innovation! #FH24 #healthinnovation #Berlin

At Angelini Ventures, we're committed to being where innovation happens. That's why our team - Lola Buono, Thomas Michael Thestrup, and Nils Bottler - attended the recent LSX Nordic Congress in Copenaghen, a key event where life science innovators and investors converged to shape the future of healthcare. A highlight was Nils' participation in the panel "Achieving Patient Centricity, Scale, and Profitability with Digital Therapeutics". Moderated by Valentin Lubbe , the discussion featured insights from industry leaders including John Drakenberg (Alex Therapeutics), Mikaela K Odlander (Orexo AB publ) , and Ann-Kathrin von Knobloch (Weigand) (Flying Health). Here are the key takeaways that caught our attention: 1️⃣ Limited Scale in Reimbursed Space: Digital therapeutics have yet to achieve significant scale in the reimbursed market. While they haven't reached traditional venture success levels, they are laying the groundwork for sustainable businesses. 2️⃣ Platform Consolidation: Emerging platform plays are consolidating the market, creating opportunities for scalable business models. These platforms can unlock value by integrating various digital therapeutic solutions and leveraging economies of scale. 3️⃣ Combination with Traditional Healthcare: The real potential lies in combining digital therapeutics with traditional drugs and healthcare services. This hybrid model offers a larger market, broader acceptance, and established reimbursement, potentially accelerating growth and patient adoption. 4️⃣ Early Days of Digital Therapeutics: Digital therapeutics are still in their early stages, but they hold significant potential to drive efficiency in care delivery. We believe that in the long run, digital therapeutics will succeed and generate robust business models in healthcare. As this dynamic field evolves, Angelini Ventures remains dedicated to fostering innovation at the cutting edge. We're excited to support and drive forward the most promising developments in healthcare technology. #DigitalTherapeutics #HealthcareInnovation #PatientCentricity #FutureOfHealthcare

At Angelini Ventures we emphasize the importance of speaking up about mental health to reduce stigma, encourage help-seeking, and transform access to critical mental health resources. We're inspired by Silvia Wang, CEO and Co-Founder of Serenis, one of our portfolio companies. Serenis is revolutionizing mental wellbeing through its innovative platform, offering online psychotherapy, coaching, counseling, and psychiatry—making professional support more accessible than ever before. We proudly support Serenis, its team and its mission. Their digital approach exemplifies how technology can break down barriers to mental health care, creating a more accessible and supportive environment for all. On this World Mental Health Day, let's commit to continuing this crucial conversation. Together, we can build a world where mental health is prioritized, understood, and accessible to everyone. #WorldMentalHealthDay #BreakTheStigma #MentalHealthAwareness #portfolio

Our London-based colleague Maya Misra represented Angelini Ventures at the Sifted Summit in London this week! Maya's key takeaways from the Summit are inspiring and reflect our forward-thinking approach: 🔹 Diverse Perspectives: The Summit showcased a variety of viewpoints on technology's role in healthcare, emphasizing the critical importance of patient-centric care. 🔹 Pragmatic Insights: Refreshingly, discussions on biotech and digital health were grounded in reality. Instead of hype, the focus was on identifying areas of tangible value. 🔹 Engaging Roundtable: Maya participated in an insightful small-group roundtable on TechBio, which included investors, startups, bankers, NHS representatives, and a bioethicist. This diverse mix of participants led to a rich and engaging discussion. These takeaways underscore why we at Angelini Ventures are passionate about staying at the forefront of health innovation. Are you part of the health innovation ecosystem? Let's connect and drive meaningful innovation in healthcare together! #siftedsummit #startupcommunity #startupconference

What an incredible experience at last week's Italian Tech Week in Turin! The event brought together international speakers and guests who offered a glimpse into the major trends shaping our world. As part of the official side events, Angelini Ventures and Exceptional Ventures had the pleasure of hosting a unique networking lunch for the most innovative minds in health, wellness, and longevity. The response was overwhelming: we welcomed over 100 participants, with many more on the waiting list. We extend our sincere thanks to all who attended and invite those who couldn't join us to stay tuned for our upcoming events. A special shout-out to Exceptional Ventures Paolo Pio Anna Fortuny-Gomez, PhD Michella Botto Andrade for being fantastic partners in co-organizing this event and thank you for having fun along the way!